mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |